Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Systemic Reactions to Trivalent Inactivated Influenza Vaccine in Healthcare Workers
NCT02263027Phase 4Completed
- Sponsor
- Mount Sinai Hospital
- Start
- Oct 2014
- Primary completion
- Jan 2016
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of trivalent inactivated influenza vaccine in influenza (2 arms), sponsored by Mount Sinai Hospital. Primary endpoint: Systemic adverse event. Started Oct 2014; status: completed.
02
Drugs
trivalent inactivated influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02263027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02263027.